Holen Sie sich die Stockscreener-App
565.93
0.89%
5.00
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$560.93
Offen:
$556.92
24-Stunden-Volumen:
590.06K
Relative Volume:
1.13
Marktkapitalisierung:
$44.95B
Einnahmen:
$4.30B
Nettoeinkommen (Verlust:
$1.06B
KGV:
43.27
EPS:
13.0798
Netto-Cashflow:
$1.04B
1W Leistung:
-3.96%
1M Leistung:
-0.75%
6M Leistung:
-11.69%
1J Leistung:
+28.33%
1-Tages-Spanne:
$552.00
$567.94
1-Wochen-Bereich:
$552.00
$592.51
52-Wochen-Spanne:
$427.70
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX vs TMO, DHR, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
565.93 | 44.95B | 4.30B | 1.06B | 1.04B | 13.08 |
TMO
Thermo Fisher Scientific Inc
|
469.71 | 174.55B | 45.20B | 6.88B | 6.75B | 18.19 |
DHR
Danaher Corp
|
177.25 | 125.45B | 24.78B | 3.68B | 5.29B | 5.1743 |
A
Agilent Technologies Inc
|
115.55 | 32.65B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
309.87 | 30.42B | 3.17B | 642.63M | 516.49M | 10.77 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Eingeleitet | Citigroup | Neutral |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-10-31 | Hochstufung | Stifel | Hold → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-08-05 | Bestätigt | BTIG Research | Buy |
| 2025-07-01 | Eingeleitet | Jefferies | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-02-17 | Eingeleitet | Barclays | Overweight |
| 2019-09-09 | Eingeleitet | Goldman | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2018-11-02 | Bestätigt | BofA/Merrill | Buy |
| 2018-05-07 | Bestätigt | Stifel | Buy |
| 2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Hochstufung | CL King | Neutral → Buy |
| 2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
| 2016-08-16 | Bestätigt | Stifel | Buy |
| 2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
| 2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-01 | Eingeleitet | CL King | Neutral |
| 2016-03-21 | Bestätigt | Stifel | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2015-10-29 | Bestätigt | Stifel | Buy |
| 2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Bestätigt | Stifel | Buy |
| 2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
Idexx outlines 2025 growth with 6-9% organic revenue target amid innovation launches - MSN
IDEXX Laboratories stock pops on Q3 beats, raised outlook - MSN
Montrusco Bolton Investments Inc. Decreases Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Krilogy Financial LLC Reduces Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Arizona State Retirement System Decreases Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Stock Rating Lowered by Wall Street Zen - MarketBeat
Why IDEXX Laboratories Stock Is Undervalued at $561 in 2026 - TIKR.com
IDEXX Laboratories, Inc. $IDXX Holdings Lifted by Teacher Retirement System of Texas - MarketBeat
IDEXX Laboratories Inc (IDXX) Shares Fall 3.0% -- What GF Score of 99 Tells Investors - GuruFocus
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Sells 3,066 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Villere ST Denis J & Co. LLC Reduces Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
M&T Bank Corp Increases Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDXX (IDEXX Laboratories Inc.) posts Q4 2025 earnings beat and double digit revenue growth, shares drop 1.86 percent today.Expansion Phase - Cổng thông tin điện tử tỉnh Tây Ninh
IDEXX Laboratories Vs. Zoetis: A Pre-Earnings Comparison (NASDAQ:IDXX) - Seeking Alpha
Zurcher Kantonalbank Zurich Cantonalbank Purchases 11,738 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
PFG Advisors Has $3.42 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
What you need to know ahead of IDEXX Laboratories' earnings release - MSN
Research Alert: CFRA Lowers Rating On Shares Of Idexx Laboratories, Inc. To Hold From Buy - Moomoo
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
What You Need to Know Ahead of IDEXX Laboratories' Earnings Release - Yahoo Finance
IDEXX Laboratories Hits Day High with Strong 3.39% Intraday Surge - Markets Mojo
IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day - MarketWatch
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A Healthcare Giant with 24% Upside Potential - DirectorsTalk Interviews
IDEXX (IDXX) launches canine cancer detection panel in UK - MSN
Local Pensions Partnership Investment Ltd Sells 9,500 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Ninety One UK Ltd Decreases Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
T. Rowe Price Diversified Mid-Cap Growth Fund, Inc.'s IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
AMG TimesSquare Mid Cap Growth Fund's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
IDEXX Laboratories stock (US45168D1046): Is its veterinary diagnostics dominance strong enough to un - AD HOC NEWS
Mirae Asset Global Investments Co. Ltd. Purchases 6,572 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc (IDXX) Shares Surge 3.4% -- What GF Score of 100 Tells Investors - GuruFocus
Is It Too Late To Consider IDEXX Laboratories (IDXX) After A 43% One Year Rally? - Yahoo Finance
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Laboratories (NASDAQ:IDXX) Stock Rating Upgraded by Citigroup - MarketBeat
Why Idexx Laboratories (IDXX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Citi Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $650 - 富途牛牛
IDEXX Laboratories, Inc. $IDXX Shares Acquired by KBC Group NV - MarketBeat
Citigroup initiates coverage of IDEXX Laboratories (IDXX) with neutral recommendation - MSN
Veterinary Infectious Disease Diagnostics Industry Analysis 2025–2031 | Key Players: IDEXX Laboratories, Inc., Zoetis, Thermo Fisher Scientific - industrytoday.co.uk
Citi Initiates IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Announces Target Price $650 - Moomoo
Is it a Prudent Move to Retain IDXX Stock in Your Portfolio Now? - TradingView
Third View Private Wealth LLC Invests $1.21 Million in IDEXX Laboratories, Inc. - National Today
Third View Private Wealth LLC Invests $1.21 Million in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Stock Up 39.4% in a Year: What's Driving It? - qz.com
Sumitomo Mitsui Trust Group Boosts IDEXX Laboratories Stake - National Today
The Bull Case For IDEXX Laboratories (IDXX) Could Change Following UK Launch Of Canine Cancer Dx Panel – Learn Why - Sahm
Retail Trends: Can IDEXX Laboratories Inc maintain sales growth2026 Pullback Review & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Robeco Institutional Asset Management B.V. Sells 20,389 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Stock Position Lifted by Sumitomo Mitsui Trust Group Inc. - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.99%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):